A Phase 3, Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 11 Jan 2018
At a glance
- Drugs Furosemide (Primary)
- Indications Warts
- Focus Therapeutic Use
- Sponsors Cutanea Life Sciences
- 05 Jan 2018 Planned End Date changed from 1 Sep 2018 to 1 Jul 2018.
- 05 Jan 2018 Planned primary completion date changed from 1 May 2018 to 1 Apr 2018.
- 05 Jan 2018 Status changed from recruiting to active, no longer recruiting.